In Trp53wt MH-22A hepatoma syngeneic model, APG-115 single agent showed no antitumor activity, whereas the anti-PD-1 antibody effectively reduced tumor volume by exhibiting a T/C (%) value of 22% on d15 (Fig. 4a). The gene discussed is PDCD1; the disease is hepatocellular carcinoma.